Breast Cancer Research

official impact factor 5.79

Viewpoint

The role of single nucleotide polymorphisms in breast cancer metastasis

James M Rae1*, Todd C Skaar2, Susan G Hilsenbeck3 and Steffi Oesterreich3

Author Affiliations

1 Division of Hematology Oncology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA

2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA

3 The Breast Center, Department of Medicine, and Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA

For all author emails, please log on.

Breast Cancer Research 2008, 10:301 doi:10.1186/bcr1842

Published: 18 January 2008

Abstract

Our understanding of many aspects of cancer biology has been advanced through the use of modern genetics. These studies have already shown that germ line polymorphisms play a significant role in disease initiation and response to therapy. However, what is less well studied is the role of germ line polymorphisms in cancer progression. Studies in rodents indicate that differential susceptibility to cancer metastasis can be heritable; thus, the search for the genes that control cancer metastasis is underway. Although some provocative studies suggest potential candidates for metastasis regulating genes, the conclusive identification of a specific inherited genetic variant that alters metastatic potential awaits further studies.